Ocugen Inc (OCGN)

0.22 -0.00  -0.54% NASDAQ Jul 6, 16:59 Delayed 2m USD
View Full Chart
Price Chart
View All Events

Events

Date Type Description
02/28/2020 Earnings Ocugen Inc Fourth Quarter Earnings Results for 2019
02/28/2020 Misc Ocugen Inc Fourth Quarter Earnings Conference Call for 2019
11/08/2019 08:30 EST Misc Ocugen Inc Third Quarter Earnings Conference Call for 2019
11/08/2019 Earnings Ocugen Inc Third Quarter Earnings Results for 2019
09/30/2019 Splits Ratio: 166667:10000000
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • URL: https://www.ocugen.com
  • Investor Relations URL: http://ir.histogenics.com/phoenix.zhtml?c=252477&p=irol-irhome
  • HQ State/Province: Pennsylvania
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Small Cap/Value
  • Next Earnings Release: N/A
  • Last Earnings Release: Feb. 28, 2020
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A
  • Description: Ocugen Inc is a clinical-stage biopharmaceutical company. It is focused on discovering, developing and commercializing a pipeline of innovative therapies that address rare and underserved eye diseases. Ocugen offers a diversified ophthalmology portfolio that includes novel gene therapies, biologics, and small molecules and targets a broad range of high-need retinal and ocular surface diseases. Its product candidate includes OCU200 and OCU300 to treat diabetic macular edema (DME), diabetic retinopathy (DR) and wet age-related macular degeneration (AMD).

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.